Home Alibaba Health Launches Vaccine Service Platform 2.0: Driving Industry Transformation Through Digital Innovation

Alibaba Health Launches Vaccine Service Platform 2.0: Driving Industry Transformation Through Digital Innovation

Oct 19, 2020 08:00 CST Updated 08:00
AliHealth

Medical and Health Services Network Service Provider

AliHealth has been making frequent moves recently. In September, AliHealth renamed its app to “Yilu” (Medical Deer), focusing on medical services with the aim of providing users with a personalized service experience. In October, AliHealth further enhanced user experience by launching version 2.0 of its Vaccine Service Platform through the AliHealth Immunization Planning Center. After logging into the Yilu app or the Alipay Medical Health channel, users can access professional vaccine-related content, receive consultation advice for childhood immunizations, quickly book appointments at community vaccination sites in selected regions, and arrange online reservations for offline administration of vaccines such as HPV and influenza vaccines, thereby enjoying comprehensive and considerate services throughout the entire vaccination process.


The launch of Vaccine Service Platform 2.0 marks AliHealth’s provision of a full-chain digital innovation solution centered on consumer services, further solidifying its leading position as an “Internet + Vaccines” platform.

Why launch the Vaccine Service Platform 2.0 at this time, and how is AliHealth further driving the development of the vaccine industry through digital innovation solutions? VCBeat reveals the answers in this article.

Under Strict Vaccine Policies and Regulations, Industry Pain Points Persist


Efforts to regulate the vaccine industry have never ceased. As early as 2004, China began to gradually establish and continuously improve its vaccine regulatory system. In 2005, the "Regulations on the Administration of Vaccine Circulation and Vaccination" were promulgated, serving as a framework document for vaccine regulation in China and standardizing the development of the vaccine industry.

Significant adjustments to regulatory policies in the vaccine industry occurred in the aftermath of two major vaccine incidents. Following the 2016 “Shandong Vaccine” incident, the State Council promulgated and implemented the revised Regulations on the Administration of Vaccine Circulation and Vaccination, which called for the elimination of the wholesale tier and the implementation of a single-invoice system for distribution. In the wake of the 2018 “Changsheng Bio-technology” incident, standalone legislation for vaccines was placed on the agenda. Subsequently, in June 2019, China enacted the Vaccine Administration Law of the People’s Republic of China. Under this legislative framework, China has instituted stringent oversight across the entire vaccine supply chain and lifecycle, encompassing research and development, manufacturing, distribution, and usage.

The highlights of the Vaccine Administration Law of the People’s Republic of China include the establishment of a comprehensive oversight system, the implementation of full-process electronic traceability and mandatory insurance for vaccines, the creation of a dynamic adjustment mechanism for vaccines under the National Immunization Program, support for the development of novel vaccines such as combination and multivalent vaccines, adherence to the strategic and public-welfare nature of vaccine products, and the encouragement of exports to create new avenues for industry growth.Stringent vaccine regulations impose new requirements on vaccine manufacturers, further squeezing the operational space of non-compliant enterprises, promoting the elevation of quality standards within the vaccine industry, and driving industry leaders to leverage their dominant positions.

The introduction of stringent regulatory laws and regulations for the vaccine industry is due to vaccine safety becoming a major challenge hindering its development.Addressing Pain Points in the Vaccine Industry: Practitioners Advocate for Strengthening Informatics to Eliminate Information Asymmetry in Vaccine Distribution and Truly Ensure Vaccine SafetyThe advantages of the Internet enable the integration of traceability information across the entire process of vaccine production, distribution, and administration. By connecting to the Marketing Authorization Holder’s (MAH) traceability system, it becomes possible to achieve full traceability and verifiability for vaccines at the smallest packaging unit throughout production, distribution, and administration. Furthermore, long-term follow-up of vaccine recipients can ensure that vaccines deliver their intended efficacy, thereby truly safeguarding vaccine safety.

In addition to the pain points faced by vaccine manufacturers in controlling vaccine production and distribution,For vaccination sites, the issues are more prominently manifested as:During vaccination campaigns, how can errors be minimized or even eliminated amidst the high volume of recipients? In the context of COVID-19 prevention and control, how can staggered vaccination schedules be implemented to reduce the risk of disease transmission? How can healthcare providers communicate efficiently with recipients to address pre-vaccination inquiries and provide post-vaccination guidance on managing adverse reactions? Additionally, how can recipient management be optimized to effectively notify individuals about missed or overdue vaccine doses?

Regulatory requirements for vaccine production and distribution traceability, coupled with the market opportunities hidden within industry pain points, along with the expanding market capacity of the vaccine industry driven by the COVID-19 pandemic under special circumstances, have enabled a large number of enterprises to identify significant opportunities., many internet giants involved in healthcare cannot ignore the field of disease prevention and vaccination, and are betting on this track to lay out their strategies. Among them, Tencent Health and Baidu Health have both entered the market by offering online booking services for HPV vaccines. AliHealthAs one of the first internet healthcare giants in China to launch online vaccine appointment services, it not only holds a dominant share in this segment but also continues to make significant strides in other areas.

Vaccine Service Platform 2.0 Launches, Empowering Organizations and Benefiting Users


It is understood that the core of AliHealth’s upgrade to its Vaccine Service 2.0 lies in transitioning from a single booking service to a comprehensive “immunization program” for the entire population.Aimed at helping every family have its own “vaccine service steward” to increase vaccination rates against the backdrop of relatively low uptake of self-paid vaccines in China; AliHealth seems to hope that, through its Vaccine Service Platform 2.0, it can “make many more friends,”AliHealth connects the upstream, midstream, and downstream segments of the vaccine industry, empowering enterprises and vaccination sites to work together in delivering convenient and reliable vaccine services to users.


微信图片_20201018092858.jpg

The first step isStrengthening the “Digital Infrastructure” for VaccinationAliHealth's "Code for Peace of Mind" traceability platform, leveraging "one item, one code" traceability technology, assigns a unique identifier to each vaccine box, enabling traceability and verification at every stage. This ensures that the source of each vaccine is identifiable and its distribution path is trackable, resolving previous information asymmetry. It helps vaccine manufacturers better monitor vaccine distribution channels and assures users of vaccine safety and reliability; addressing the critical challenges faced by vaccination sites,AliHealth developed the "Time-Slot Appointment Tool" for it., to help vaccination sites systematically plan and manage users, thereby reducing the risk of disease transmission;Automatically match vaccine appointment information using tools such as facial recognition, reducing the incidence of vaccination errors;Provide doctors with an online consultation channel, providing answers to users' complex questions;Provide vaccination sites with efficient tools for user outreach, and reminding about catch-up vaccinations, among other matters.

Step 2 is to provide user-centric services. When using AliHealth’s Vaccine Service Platform 2.0, users can enjoy the following core features:

Time-Slot Appointment Service:All users requiring vaccination should, for epidemic prevention and control purposes, strive to avoid close contact with densely crowded groups in offline settings. AliHealth Service Platform 2.0 provides vaccination sites with a "time-slot appointment tool," enabling them to set their own service hours, export appointment information, and schedule the number of individuals served per time slot. This helps users reduce their risk of exposure to infectious diseases. AliHealth noted that selected vaccination sites in 33 cities, including Guiyang, Yinchuan, Harbin, and Wenzhou, have already begun using the time-slot appointment tool. Users can make online appointments to reasonably plan their vaccination timing. The service is currently undergoing rapid iteration to continuously meet the needs of both vaccination sites and users. Furthermore, this service is permanently free of charge for both vaccination sites and users.

Intelligent Vaccine Scheduling Service:Before the age of two, toddlers require at least 18 vaccine doses, with visits to vaccination centers several times a month during the first six months. This places a heavy workload on vaccination centers and increases the risk of missed doses for parents. Now, by simply entering their child’s vaccination history into the Yilu App or the Health Channel on Alipay, parents can receive intelligent vaccination recommendations covering both free and paid vaccines, as well as access a “Reminder and Attention” service.


City-Level Appointment Services:In certain regions, users can access online appointment services for specific vaccines at community health service centers. After confirmation by a physician, users can schedule their vaccinations online, thereby reducing waiting times for in-person visits. It is reported that this feature has been implemented at selected vaccination sites in Zhejiang Province, Guangzhou, Jinan, Harbin, Hefei, and Haikou, with plans for gradual expansion. Leveraging its stable technical service capabilities, AliHealth is supporting the continuous expansion of government public welfare services, serving as a robust supplement.


Popular Vaccines: Register Early, Book Early, Get Vaccinated Early:Users with high demand for popular vaccines will also enjoy a one-stop service experience for registration, appointment scheduling, and vaccination on the AliHealth Vaccine Service Platform 2.0. Whether it is the HPV vaccine, which is frequently out of stock and difficult to book, or influenza and 13-valent pneumococcal conjugate vaccines, whose demand has surged due to the pandemic leading to supply shortages, users can follow the process of “registering their demand – receiving vaccination reminders – making online appointments” via the Yilu app or the Alipay Health channel once healthcare providers enable the service. Vaccination sites operate based on allocated quotas and the number of registrations; upon vaccine arrival, the system can send targeted notifications to registered users, who can then schedule their appointments online and confirm their vaccination times in a single step.

In fact, the capabilities of AliHealth’s Vaccine Service Platform 2.0 have been acquired through continuous development.

Digital Innovation Solutions Cement Its Leading Position as an “Internet + Vaccines” Platform


It is understood that AliHealth has long been active in the “Internet + Vaccines” sector.As early as three years ago, in August 2017, AliHealth partnered with GSK to launch vaccine education initiatives.In December of the same year, China National Biotec Group (CNBG) entered into a strategic partnership with AliHealth, listing its services on AliHealth’s Adult Vaccination Service Platform, which marked the platform’s inaugural launch. Subsequently, in 2018, AliHealth collaborated with MSD, the manufacturer of quadrivalent and nonavalent HPV vaccines, to deliver digital, precision-based educational services for cervical cancer vaccination.


In the same year, AliHealth launched its platform in response to the high-profile vaccine incident."Vaccine Lookup Tool", leveraging the digital infrastructure capability of “Ma Shang Fang Xin” to help users query the precise batch numbers of administered vaccines, thereby ensuring greater peace of mind during vaccination. In 2019,This service capability has been further upgraded. In accordance with national vaccine traceability standards, AliHealth has upgraded and transformed its end-to-end traceability platform.By scanning the 20-digit traceability code starting with “8” on the vaccine box via Taobao Mobile or Alipay, consumers can verify the manufacturer and expiration date of the vaccine. Moreover, they can trace the vaccine’s distribution path to identify the specific Center for Disease Control and Prevention (CDC) and vaccination site it originated from, thereby enhancing vaccinatees’ confidence in the safety of the inoculation.

 

This year, amid the impact of the COVID-19 pandemic, AliHealthIn April, the "Vaccination Time-Slot Reservation" mini-program was urgently launched., helping vaccination sites systematically plan their service delivery to users, which can also be regarded as an early prototype of a “time-slot appointment tool.”August, AliHealth in 25 cities across China, including Beijing, Shanghai, and ChongqingFlu Vaccine Appointment and Vaccination Service Now AvailableSeptember, AliHealth has also signed a strategic cooperation agreement with Sinovac Biotech Ltd.,Collaborate on the “Internet + Vaccines” digital platform, online vaccine appointment scheduling, full-process vaccine traceability, post-vaccination health follow-ups, and public education on vaccines.It is reported that the collaboration between the two parties also involves the establishment of a COVID-19 vaccine platform.

 

Beyond serving users,Vaccination Service Providersis also extremely important. AliHealthEquipped vaccination sites with the “AliHealth Vaccine Intelligent Assistant,” providing inoculation physicians with online consultation and diagnostic channels, and establishing city-specific, customized “intelligent + human” service systems.AliHealth also stated that its service capabilities would be made freely available to all vaccination sites.

It is precisely these continuous strategic initiatives and advancing collaborations that have enabled AliHealth to launch its Vaccine Service Platform 2.0. Compared with Vaccine Service Platform 1.0,The all-new Vaccine Service Platform 2.0 boosts vaccination rates and user satisfaction while reducing the incidence of corresponding infectious diseases by producing content, providing tools, engaging in joint promotion, and offering convenient digital fulfillment channels.

Obviously, building service capabilities is merely the foundation; a point that cannot be overlooked is that,Backed by Alibaba Group, AliHealth enjoys the inherent advantage of leveraging ecosystem capabilities to expand service coverage. With its new YiLu app as a central hub, AliHealth can synchronize high-quality content, convenient tools, and service capabilities across apps such as UC Browser, Quark, Tmall, and Alipay., covering full scenarios such as search, livelihood services, payments, and shopping, thereby reaching users more broadly.

Digital Vaccine Innovation Solutions Are Imperative in the Era of Normalized Epidemic Prevention and Control


Driven by the impact of the COVID-19 pandemic, the vaccine industry has accelerated its development, and digital innovation, as a core capability for enhancing efficiency, will inevitably accelerate in tandem.

For the disease control and prevention system, digital innovation solutions will effectively provide support in response to the needs of epidemic prevention and control. We have also observed thatDisease control and prevention systems in Zhejiang, Shanghai, Jiangsu, and other regions are accelerating the adoption of digital innovation solutions to enhance public health services in the vaccine industry. Ultimately, this will enable individuals to receive more convenient, comfortable, safe, and reassuring services throughout the pre-vaccination, vaccination, and post-vaccination stages.

For the industry,AliHealth has launched Vaccine Service Platform 2.0 at this juncture, creating an innovative digital solution for the vaccine sector from a corporate perspective. By synergizing with government public welfare services, this initiative will exert a profound impact on the digitalization of consumer services in the vaccine industry., truly reducing the burden on vaccination units and improving comprehensive service efficiency, thereby making vaccinations more convenient for the public, increasing vaccination rates, and promoting healthier lives.